Global Diabetes Care Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

November 2017 | 219 pages | ID: G4846FB57E6EN
Precision Business Insights (PBI)

Abstracts

Global Diabetes Care Devices Market:

Global diabetes care devices market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for diabetes care devices is projected to reach US$ XX Mn by 2023.

Diabetes is the most widespread metabolic disorder in which patient body is unable to use the glucose due to the lack of Insulin. The major cause of diabetes is insulin deficiency secreted by beta cells of the islet of Langerhans of the pancreas. The other factors include genetically inheritance, changing lifestyle, and unhealthy diets can also cause diabetes. Diabetes further has severe effects on the body like internal damaging of organs and hence require regular monitoring and controlled level of glucose levels in the body. Diabetes care devices are user-friendly and can be operated by patients themselves; they monitor the blood glucose level and help patients to control diabetes. There are two different type of diabetes, caused due to decreasing ability of the pancreas to produce the insulin and another is due to lack of response to the insulin. Diabetes is a chronic disease and the people suffering from diabetes needs to monitor blood glucose throughout their life.

Global diabetes care devices market is growing at a significant rate due to the increase in the incidence of diabetes, especially in adults. The key drivers for the growth of global diabetes care devices market are rise in innovative technologies, minimally or non-invasive products and increasing diabetic population boosting the growth of global diabetes care devices market. Similarly, availability of devices, that are faster, effective, safer, and user-friendly are the key factors fuel the growth of the global diabetes care devices market over the forecast period. Apart from this, government and private investment in research and development, and low diagnostic rates might fuel the growth of global diabetes care devices market. However, the high cost of new devices, lack of awareness, stringent regulatory obligations, and disparity in reimbursements are some the factors that are constraining the growth of global diabetes care device market.

Global diabetes care devices market has been segmented on the basis of product type, and distribution channel

Based on product type, global diabetes care devices market has been segmented into the following:

• Blood glucose monitoring devices
• Self-monitoring blood glucose meters
• Continuous glucose meters
• Consumables
• Others
• Insulin delivery devices
• Insulin syringes
• Insulin pens
• Insulin pumps
• Insulin jet injectors

Based on distribution channel, global diabetes care devices market has been segmented into the following:

• Hospital pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Globally, diabetes is the fourth leading cause of death. According to the International Diabetes Federation (IDF), seven Mn people are added every year to the pool of 246 Mn diabetics, which is projected to increase approximately 438 Mn by 2030. Moreover, about 3.8 Mn people die each year from diabetes. The global diabetes care devices market is highly fragmented with the presence of several large and small vendors, due to which it witnesses an intensely competitive environment. For the development of new products, and enhance the competitiveness, most vendors partnering with other vendors in the global diabetes care devices market. For instance, in June 2016, Ascensia Diabetes Care partnered with Medtronic for developing and marketing diabetes management solutions. Furthermore, to develop and market test strips and blood glucose meters, vendors are also undertaking strategic alliances due to which the market presents a significant opportunity for new players in the global diabetes care devices market. In 2000, Minimed has launched the Continuous Glucose Monitoring System in the global diabetes care devices market which measures and store glucose values for 3 days. Further, the device is developed to store the results up to 6 or 7 days and helps to see data in the real time. For instance, Medtronic (Enlite, Guardian Realtime), Abbott (Freestyle Navigator II), and Dexcom’s (G4 Platinum)

Geographically, the diabetes care devices market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the markets followed by Europe and Asia-Pacific. North America garners significant market share due to the growing diabetic population. According to American Diabetes Association, the prevalence of diabetes in 2015 is 30.3 Mn or 9.4% in U.S., availability of skilled professionals, and reimbursement for the diabetes care devices are the major factors contributing to the growth of the global diabetes care devices market in North America. Europe is the second largest region for global diabetes care devices market in the world due to the rapidly aging population and drastic changes in lifestyle. Asia-Pacific region is major market for global diabetes care devices due to the large patient pool, and rising diabetes incidence in the region. According to the International Diabetes Federation (IDF), China has the largest number of diabetic patients with around 96.2 Mn and India has around 66.8 Mn diabetic patients, which represents approximately 45% of the global diabetic population. Aforementioned factors help to boost diabetes care devices market in Asia-Pacific region.

Some of the players in global diabetes care devices market are Abbott Laboratories (Abbott, Inc.) (U.S.), Dexcom Inc. (U.S.), Johnson & Johnson Services Inc.(U.S.), Merck & Co, Inc. (U.S.), F. Hoffman-La Roche (Switzerland), Becton-Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Bayer AG (Germany), Medtronic plc. (Ireland), Terumo Corporation, Inc. (Japan), Ascensia Diabetes Care (U.S.) Panasonic Healthcare Holdings Co. Ltd. (Japan) and Eli Lilly and Company (U.S.) to name a few.

In December 2015, Novo Nordisk and IBM Watson Health partnered to create diabetes solutions built on the Watson Health Cloud

In June 2015, Panasonic Healthcare acquired Bayer diabetes unit’s Contour portfolio of blood glucose monitoring meters and strips

REPORT OUTLINE:

• The report provides granular level information about the market size, regional market share and forecast from 2017-2023
• The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
• The Report Outlines drivers, restraints, challenges, and trends that are currently faced by the industry
• The report tracks recent innovations, key developments and startup’s details that are working in the industry
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL DIABETES CARE DEVICES MARKET INTRODUCTION

2.1. Global Diabetes Care Devices Market – Taxonomy
2.2. Global Diabetes Care Devices Market – Definitions
  2.2.1. Product Type
  2.2.2. Distribution Channel

3. GLOBAL DIABETES CARE DEVICES MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Diabetes Care Devices Market Dynamics – Factors Impact Analysis
3.6. Global Diabetes Care Devices Market– Regulations
  3.6.1. U.S
  3.6.2. Europe
  3.6.3. Japan

4. GLOBAL DIABETES CARE DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Self-Monitoring Blood Glucose Meters
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Continuous Glucose Meters
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. Consumables
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. Insulin Syringes
  5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis
5.5. Insulin Pens
  5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis
5.6. Insulin Pumps
  5.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.6.3. Market Opportunity Analysis
5.7. Insulin Jet Injectors
  5.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.7.3. Market Opportunity Analysis
5.8. Others
  5.8.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.8.3. Market Opportunity Analysis

6. GLOBAL DIABETES CARE DEVICES MARKET FORECAST, BY DISTRIBUTION CHANNEL, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. Hospital Pharmacies
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Retail Pharmacies
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Online Pharmacies
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis

7. GLOBAL DIABETES CARE DEVICES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. North America
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Europe
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Asia-Pacific
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis
7.4. Latin America
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.4.3. Market Opportunity Analysis
7.5. Middle East and Africa
  7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.5.3. Market Opportunity Analysis
7.6. Global Diabetes Care Devices Market- Opportunity Analysis Index - By Product Type, By Distribution Channel, and Region, 2017 – 2023

8. NORTH AMERICA DIABETES CARE DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  8.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    8.1.1.1. Blood glucose monitoring devices
      8.1.1.1.1. Self-monitoring Blood Glucose Meters
      8.1.1.1.2. Continuous Glucose Meters
      8.1.1.1.3. Consumables
      8.1.1.1.4. Others
    8.1.1.2. Insulin delivery devices
      8.1.1.2.1. Insulin Syringes
      8.1.1.2.2. Insulin Pens
      8.1.1.2.3. Insulin Pumps
      8.1.1.2.4. Insulin Jet Injectors
  8.1.2. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    8.1.2.1. Hospital Pharmacies
    8.1.2.2. Retail Pharmacies
    8.1.2.3. Online Pharmacies
  8.1.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    8.1.3.1. U.S.
    8.1.3.2. Canada
  8.1.4. North America Diabetes Care Devices Market- Opportunity Analysis Index - By Product Type, By Distribution Channel, and Country, 2017 – 2023
  8.1.5. North America Diabetes Care Devices Market Dynamics – Trends

9. EUROPE DIABETES CARE DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  9.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    9.1.1.1. Blood glucose monitoring devices
      9.1.1.1.1. Self-monitoring Blood Glucose Meters
      9.1.1.1.2. Continuous Glucose Meters
      9.1.1.1.3. Consumables
      9.1.1.1.4. Others
    9.1.1.2. Insulin delivery devices
      9.1.1.2.1. Insulin Syringes
      9.1.1.2.2. Insulin Pens
      9.1.1.2.3. Insulin Pumps
      9.1.1.2.4. Insulin Jet Injectors
  9.1.2. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.2.1. Hospital Pharmacies
    9.1.2.2. Retail Pharmacies
    9.1.2.3. Online Pharmacies
  9.1.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    9.1.3.1. Germany
    9.1.3.2. UK
    9.1.3.3. France
    9.1.3.4. Spain
    9.1.3.5. Italy
    9.1.3.6. Russia
    9.1.3.7. Poland
    9.1.3.8. Rest of Europe
  9.1.4. Europe Diabetes Care Devices Market- Opportunity Analysis Index - By Product Type, By Distribution Channel Type, and Country, 2017 – 2023
  9.1.5. Europe Diabetes Care Devices Market Dynamics – Trends

10. ASIA-PACIFIC DIABETES CARE DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  10.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    10.1.1.1. Blood glucose monitoring devices
      10.1.1.1.1. Self-monitoring Blood Glucose Meters
      10.1.1.1.2. Continuous Glucose Meters
      10.1.1.1.3. Consumables
      10.1.1.1.4. Others
    10.1.1.2. Insulin delivery devices
      10.1.1.2.1. Insulin Syringes
      10.1.1.2.2. Insulin Pens
      10.1.1.2.3. Insulin Pumps
      10.1.1.2.4. Insulin Jet Injectors
  10.1.2. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    10.1.2.1. Hospital Pharmacies
    10.1.2.2. Retail Pharmacies
    10.1.2.3. Online Pharmacies
  10.1.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
    10.1.3.1. Japan
    10.1.3.2. China
    10.1.3.3. India
    10.1.3.4. ASEAN
    10.1.3.5. Australia & New Zealand
    10.1.3.6. Rest of Asia-Pacific
  10.1.4. Asia-Pacific Diabetes Care Devices Market- Opportunity Analysis Index - By Product Type, By Distribution Channel Type, and Country, 2017 – 2023
  10.1.5. Asia-Pacific Diabetes Care Devices Market Dynamics – Trends

11. LATIN AMERICA DIABETES CARE DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  11.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    11.1.1.1. Blood glucose monitoring devices
      11.1.1.1.1. Self-monitoring Blood Glucose Meters
      11.1.1.1.2. Continuous Glucose Meters
      11.1.1.1.3. Consumables
      11.1.1.1.4. Others
    11.1.1.2. Insulin delivery devices
      11.1.1.2.1. Insulin Syringes
      11.1.1.2.2. Insulin Pens
      11.1.1.2.3. Insulin Pumps
      11.1.1.2.4. Insulin Jet Injectors
  11.1.2. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.2.1. Hospital Pharmacies
    11.1.2.2. Retail Pharmacies
    11.1.2.3. Online Pharmacies
  11.1.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    11.1.3.1. Brazil
    11.1.3.2. Mexico
    11.1.3.3. Argentina
    11.1.3.4. Venezuela
    11.1.3.5. Rest of Latin America
  11.1.4. Latin America Diabetes Care Devices Market- Opportunity Analysis Index - By Product Type, By Distribution Channel Type, and Country, 2017 – 2023
  11.1.5. Latin America Diabetes Care Devices Market Dynamics – Trends

12. MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

  12.1.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    12.1.1.1. Blood glucose monitoring devices
      12.1.1.1.1. Self-monitoring Blood Glucose Meters
      12.1.1.1.2. Continuous Glucose Meters
      12.1.1.1.3. Consumables
      12.1.1.1.4. Others
    12.1.1.2. Insulin delivery devices
      12.1.1.2.1. Insulin Syringes
      12.1.1.2.2. Insulin Pens
      12.1.1.2.3. Insulin Pumps
      12.1.1.2.4. Insulin Jet Injectors
  12.1.2. Distribution Channel Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    12.1.2.1. Hospital Pharmacies
    12.1.2.2. Retail Pharmacies
    12.1.2.3. Online Pharmacies
  12.1.3. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    12.1.3.1. Gulf Cooperation Council (GCC) Countries
    12.1.3.2. Israel
    12.1.3.3. South Africa
    12.1.3.4. Rest of MEA
  12.1.4. MEA Diabetes Care Devices Market- Opportunity Analysis Index - By Product Type, By Distribution Channel, and Country, 2017 – 2023
  12.1.5. MEA Diabetes Care Devices Market Dynamics – Trends

13. COMPETITION LANDSCAPE

13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  13.2.1. Abbott Laboratories (U.S.)
  13.2.2. Dexcom Inc. (U.S.)
  13.2.3. Johnson & Johnson Services Inc.(U.S.)
  13.2.4. Merck & Co, Inc. (U.S.)
  13.2.5. F. Hoffman-La Roche (Switzerland)
  13.2.6. Becton-Dickinson and Company (U.S.)
  13.2.7. Novo Nordisk A/S (Denmark)
  13.2.8. Bayer AG (Germany)
  13.2.9. Medtronic plc. (Ireland)
  13.2.10. Terumo Corporation, Inc. (Japan)
  13.2.11. Ascensia Diabetes Care (U.S.)
  13.2.12. Panasonic Healthcare Holdings Co. Ltd. (Japan)
  13.2.13. Eli Lilly and Company (U.S.)

14. RESEARCH METHODOLOGY

15. KEY ASSUMPTIONS AND ACRONYMS